Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output (Q34031011)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output
scientific article

    Statements

    Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output (English)
    Jean-Christophe Saurin
    Pierre-Jean Valette

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit